This most current twist within the Lykos Therapeutics saga threatens a major overhaul of the company’s system and direction, with Musk ally and billionaire Trader Antonio Gracias showing to desire to get the company back again toward its nonprofit drug advancement roots and a far more Doblinite philosophy.The most hotly argued story, needless to